Study of the Interactions of Bovine Serum Albumin with the New Anti-Inflammatory Agent 4-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)-N′-[(4-ethoxy-phenyl)methylidene]benzohydrazide Using a Multi-Spectroscopic Approach and Molecular Docking
The lipophilic derivative of thalidomide (4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N′-[(4-ethoxyphenyl)methylidene]benzohydrazide, 6P) was synthesized to enhance its characteristics and efficacy. Earlier studies have proved the immunomodulatory and anti-inflammatory effects of 6P. In this study th...
Main Authors: | Tanveer A. Wani, Ahmed H. Bakheit, Abdul-Rahman A. Al-Majed, Mashooq A. Bhat, Seema Zargar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-07-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/22/8/1258 |
Similar Items
-
Crystal structure of (S)-4-carbamoyl-4-(1,3-dioxoisoindolin-2-yl)butanoic acid
by: Kohei Otogawa, et al.
Published: (2015-01-01) -
Crystal structure of the thalidomide analog (3aR*,7aS*)-2-(2,6-dioxopiperidin-3-yl)hexahydro-1H-isoindole-1,3(2H)-dione
by: Yousef Hijji, et al.
Published: (2018-11-01) -
Jane /
by: 337338 Leong, Mary Jane
Published: (1985) -
Eosinophilia as an adverse drug reaction secondary to thalidomide therapy in Lepra type 2 reactions: a mandate responsibility
by: Deeptanshu Nirmal Chandu, et al.
Published: (2019-12-01) -
Thalidomide: near complete regression of extramedullary bulk in refractory multiple myeloma
by: A Anagnostara, et al.
Published: (2001-03-01)